Sequel Therapeutics

Apollo Therapeutics

This biopharmaceutical company develops new medicines based on medical research for patients with various therapeutic needs.

Saol Therapeutics

This pharmaceutical company develops clinical-stage therapies for patients with central nervous system disorders, pain, spasticity and orphan diseases.

Melius Pharma

The company develops pharmaceutical treatments for chronic cough in patients with idiopathic pulmonary fibrosis.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Enemsa Pharma

This company develops small-molecule neuroprotective therapies and combination drugs to treat patients with rare neurodegenerative and cardiopulmonary diseases.

MDI Therapeutics

This pharmaceutical company develops serpin-based therapies to treat patients with chronic fibrosis, inflammatory diseases and fibroproliferative disorders.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.